SCHEMBL30567243

CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C

nearest known ligand 0.66

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	APLNR	P35414	2/20	0.58

▸	CALCR	P30988	6/20	0.55

▸	NPY2R	P49146	6/20	0.55

▸	NPY4R	P50391	6/20	0.55

▸	NPY5R	Q15761	6/20	0.55

▸	NPY1R	P25929	4/20	0.55

▸	RAMP3	O60896	3/20	0.55

▸	NMUR2	Q9GZQ4	1/20	0.54

▸	NMUR1	Q9HB89	1/20	0.54

▸	C5AR1	P21730	1/20	0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30272469	0.89	APLNR (0.58)	APLNRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30974066	0.89	NMUR2 (0.60)	CALCRRAMP3NMUR2NMUR1
SCHEMBL30974482	0.89	NMUR2 (0.60)	APLNRCALCRRAMP3NMUR2NMUR1
SCHEMBL30977975	0.88	CALCR (0.65)	CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30495756	0.88	CALCR (0.64)	APLNRCALCRNPY2RNPY4RNPY5R
SCHEMBL31255218	0.88	APLNR (0.57)	APLNRCALCRRAMP3
SCHEMBL31182771	0.88	CXCR4 (0.62)	NPY2RNPY4RNPY5RNPY1RC5AR1
SCHEMBL29649207	0.88	MAPK8 (0.58)	CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30433007	0.88	CALCR (0.65)	CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL29827447	0.88	KEAP1 (0.62)	CALCRNPY2RNPY4RNPY5RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2023171982-A1	COMPOSITION FOR PREVENTING OR TREATING OBESITY, DIABETES, OR NASH COMPRISING SHLP2 AS ACTIVE INGREDIENT	연세대학교 산학협력단	2023-09-14	—	—	WO	disclosed